Crospon hires specialist sales leader on eve of commercial launch
This article was originally published in Clinica
Crospon (Galway, Ireland) has appointed Larry Fulton (see people profile on this page), an experienced sales leader for bariatric-related minimally invasive devices, as vice-president of sales for Canada, and Central and South America. Mr Fulton joins from Endogastric Solutions (Washington), where he was director of sales for the US, Mexico and Canada. Experienced in moving a product from concept to commercialisation, his appointment comes at a critical moment, with the firm preparing to launch its CE-marked EndoFLIP system for diagnosis of the condition of the gastroesophageal junction.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.